-
Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial
Einerhand, S. M. H., Ali, H., Wong, S. Q., van Dorp, J., van Maanen, T., de Feijter, J. M., Montfoort, M. L. V., Boellaard, T. N., Braaf, L. M., Brugman, W., Vis, D. J., Hollander, C. M. J., Daletzakis, A., Schrijver, H. A., Snapper, K., Oosting, S. F., Bruijnen, C. P., Wessels, L. F. A., Chan, K. S. & Suelmann, B. B. M. & 1 others, , 1 Dec 2026, In: Nat. Commun.. 17, 1, 7679.Research output: Contribution to Journal › Article › Academic › peer-review
-
European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update
Parnham, A., Albersen, M., Ayres, B., Crook, J., Johnstone, P. A. S., Oliveira, P., Pagliaro, L. C., Pettaway, C., Protzel, C., Bryan Rumble, R., Sánchez Martínez, D. F., Spiess, P. E., van der Heijden, M. S., Barreto, L., Garcia-Perdomo, H. A., Greco, I., Patterson, K., Manzie, K., Marcus, J. D. & Osborne, J. & 3 others, , Jul 2026, In: European Urology. 90, 1, p. 60-71 12 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial
Mellema, J.-J. J., Stockem, C. F., Herberts, C., Cheung, S. K., Vis, D. J., van Rhijn, B. W. G., Mertens, L. S., Boellaard, T. N., van Montfoort, M. L., Balduzzi, S., de Feijter, J. M., van der Mijn, J. C. K., Sharma, S., el Naggar, A. C., Boormans, J. L., Franckena, M., Meijer, R. P., Noteboom, J. L., Schaake, E. E. & Robbrecht, D. G. J. & 2 others, , 1 Apr 2026, In: Nature Medicine. 32, 4, p. 1241-1248 8 p.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
